Lv31
310 积分 2021-07-05 加入
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
15天前
已完结
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
15天前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
15天前
已完结
Pairing up with GLP-1 to combat obesity
15天前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
15天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
15天前
已完结
NK2R agonist delivers one-two punch to obesity
15天前
已完结
Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: A systematic review and network meta-analysis
19天前
已关闭
Fourth-generation EGFR-TKI to overcome C797S mutation: past, present, and future
19天前
已完结
Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer?
19天前
已完结
皖公网安备34019202002308
